Center for Eye Research Australia
18
6
6
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
22.2%
4 terminated/withdrawn out of 18 trials
60.0%
-26.5% vs industry average
11%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Defining Retinal Structures Using Hyperspectral Retinal Imaging
Role: lead
Detecting Beta-amyloid in the Retina
Role: lead
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
Role: lead
Defining Retinal and Choroidal Structures Using Hyperspectral Imaging
Role: lead
Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment
Role: lead
Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study
Role: lead
Laser Intervention in Early Age-Related Macular Degeneration Study
Role: lead
Functional Assessments in Vision Impairment
Role: lead
Longitudinal Study of a Bionic Eye
Role: lead
Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
Role: collaborator
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
Role: lead
A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent
Role: collaborator
The Glaucoma Nicotinamide Trial
Role: collaborator
Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)
Role: collaborator
Study of a Suprachoroidal Retinal Prosthesis
Role: collaborator
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
Role: lead
Pilot Study of a Suprachoroidal Retinal Prosthesis
Role: lead
Incidence of Retinopathy and Associated Risk Factors in Children and Young Adults With Type 1 Diabetes in Denmark
Role: collaborator
All 18 trials loaded